Durable Reductions in HbA1c, Body Weight Seen With Semaglutide

Use of once-weekly subcutaneous semaglutide is associated with sustained reductions in hemoglobin A1c and body weight.

Related Keywords

Israel ,Hamburg ,Germany ,Cheli Melzer Cohen ,Avraham Karasik ,Maccabi Health Services ,European Association For The Study Of Diabetes ,Novo Nordisk ,Maccabi Health Services In Tel Aviv ,Healthday News ,European Association ,Tel Aviv ,